HomeMarkets overviewSharesCarl Zeiss Meditec AG

Trade Carl Zeiss Meditec AG - AFX CFD

31.44+3.15%
The chart shows the AFX stock price data over the last 1 day, with a current price of 31.44, a high of 31.4, and a low of 30.54.
Low: 30.54High: 31.4
Sellers:
0%
Buyers:
100%
Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.16
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.018016 %
(-€3.60)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.01802%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.004207 %
(-€0.84)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.00421%
Overnight funding adjustment time21:00 (UTC)
CurrencyEUR
Min traded quantity0.1
Margin5.00%
Stock exchangeGermany
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close30.48
Open30.54
1-Year Change-33.42%
Day's Range30.54 - 31.4

Trade Carl Zeiss Meditec AG - AFX

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.

Financial summary

BRIEF: For the three months ended 31 December 2021, Carl Zeiss Meditec AG revenues increased 11% to EUR410.2M. Net income decreased 18% to EUR37.9M. Revenues reflect Ophthalmic Devices segment increase of 10% to EUR310.9M, Microsurgery segment increase of 16% to EUR99.3M, Asia/Pacific Region segment increase of 15% to EUR181.5M, EMEA segment increase of 5% to EUR114.1M.

Equity composition

10/2006, Rights Issue, 3 new shares for every 2 shares held @ EUR 10.1 (Factor: 1.369066).

Latest shares articles

Soitec logo displayed in front of a blurred stock market chart with green and red candlesticks.
Soitec stock forecast: €500m ORNANE bond
Soitec is a French semiconductor materials company. In September 2026, it placed €500m of 0.5% ORNANEs due in 2033, with settlement expected on 25 September. Explore third-party SOI price targets and technical analysis. Past performance is not a reliable indicator of future results.
16 minutes ago
Stuttgart, Germany - 03-10-2021: Person holding smartphone with logo of airline company International Airlines Group (IAG) on screen in front of website. Focus on phone display. Unmodified photo.
IAG share price forecast: flying high or waiting in the wings?
IAG, the airline group behind British Airways, completed a €500m share buyback in September 2026, while BA announced plans to increase Latin American seat capacity by 25% for summer 2027. Explore third-party IAG price targets. Past performance is not a reliable indicator of future results.
37 minutes ago
Vossloh stock forecast: RTI acquisition expands digital rail
Vossloh is a German rail-infrastructure group that completed its acquisition of Rail Technology International on 15 September, expanding its digital inspection and analytics offering. Explore third-party VOS price targets. Past performance is not a reliable indicator of future results.
24 hours ago
Viking Therapeutics stock forecast: VK2735 Phase III progress
Viking Therapeutics is developing VK2735 for obesity, with two Phase III VANQUISH trials fully enrolled and maintenance-dosing results due this quarter. Explore third-party VKTX price targets and technical analysis. Past performance is not a reliable indicator of future results.
10:39, 23 September 2026

User feedback and ratings

2025-07-01
V***** F******* N***** S****

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-06-30
B******

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-06-27
G** G******

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-06-19
d*********

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-06-19
f*********

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-05-29
C*********

Love the TV integration. Makes traders life smooth and comfortable.

2025-05-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-04-29
d******

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-02-06
N***** B***

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

2025-06-29
p*******

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready